ARE THERE ANY DIFFERENCES IN THE EFFECTIVITY AND SAFETY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS ACCORDING THEIR GENDER?

Por: Garcia, R, Fernandez-Prada, M, Conesa, A, Esteban, JC, Urruticoechea-Arana, A, Olive, A, Paredes, S, Taverner, D and Gonzalez, C

---

Publicada: 1 jun 2019

---

---

Filiaciones:
Garcia, R:
 Hosp Virgen de la Victoria, Rheumatol, Malaga, Spain

Fernandez-Prada, M:
 Hosp Univ Guadalajara, Rheumatol, Guadalajara, Spain

Conesa, A:
 Hosp Gen Univ Castello, Rheumatol, Castellon de La Plana, Spain

Esteban, JC:
 Hosp Univ Puerta de Hierro, Rheumatol, Madrid, Spain

Urruticoechea-Arana, A:
 Hosp Can Misses, Rheumatol, Eivissa, Spain

:
 Hosp Badalona Germans Trias & Pujol, Badalona, Spain

Paredes, S:
 Hosp Univ St Joan Reus, Reus, Spain

Taverner, D:
 Hosp Univ St Joan Reus, Reus, Spain

Gonzalez, C:
 Hosp Gen Univ Gregorio Maranon, Rheumatol, Madrid, Spain